Northwest Biotherapeutics Inc (NASDAQ:NWBO)

CAPS Rating: 1 out of 5

Recs

1
Player Avatar martynanasi (98.39) Submitted: 3/11/2014 12:10:09 PM : Outperform Start Price: $9.94 NWBO Score: -55.00

Recently approved drug DCVax-L apporved in Germany ahead of phase III trail completion. WIll be allowed to prescribed for 5yr and can be extended. Previous trials point to sustain life span of existing brain cancer tumor patients. See huge upside

Featured Broker Partners


Advertisement